Surgery Partners (SGRY) Cash from Investing Activities (2014 - 2026)

Surgery Partners has reported Cash from Investing Activities for 13 years, with the latest figure at -$13.4 million in Q1 2026.

• Quarterly Cash from Investing Activities rose 82.46% year-over-year to -$13.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$183.6 million (up 61.89% YoY) and the FY2025 annual result came in at -$246.6 million, up 49.52% from the prior year.
• Cash from Investing Activities grew to -$13.4 million in Q1 2026 per SGRY's latest filing, from -$126.1 million in the prior quarter.
• Over five years, Cash from Investing Activities peaked at $2.1 million in Q2 2025 and troughed at -$244.1 million in Q2 2024.
• A 5-year average of -$75.4 million and a median of -$70.7 million in 2023 frame the typical range for Cash from Investing Activities.
• The sharpest annual moves came in 2022 and 2025: Cash from Investing Activities plunged 408.71% in 2022, then soared 100.86% in 2025.
• Over 5 years, Cash from Investing Activities stood at -$72.2 million in 2022, then climbed by 19.53% to -$58.1 million in 2023, then sank by 92.25% to -$111.7 million in 2024, then fell by 12.89% to -$126.1 million in 2025, then soared by 89.37% to -$13.4 million in 2026.
• According to Business Quant data, Cash from Investing Activities over the past three periods registered -$13.4 million, -$126.1 million, and -$46.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.